Fig. 5.
Effect of RSV on Wnt/β-catenin signaling. a ALP activity in mMSCs treated with RSV (40 μM) with or without ICG-001 (10 μM) before the addition of PMMA particles. b The mRNA expression levels of Runx2, Osterix and OCN in mMSCs treated with RSV (40 μM) with or without ICG-001 (10 μM) before the addition of PMMA particles. c Osteoblastic differentiation in mMSCs treated with RSV (40 μM) with or without ICG-001 (10 μM) before the addition of PMMA particles assessed by ARS staining. *P < 0.05 compared with control group. &P < 0.05 compared with PMMA group. #P < 0.05 compared with PMMA + 40 μM RSV group